Abstract

AimSeveral studies suggest that a low pre-dialysis serum albumin level (<40g/L) is associated with increased mortality in dialysis patients. The objective of this study was to assess if hemodialysis session duration (HSD), ultrafiltration rate (UFR) and interdialytic weight gain percentage (IDWG%) are associated with pre-dialysis serum albumin levels (markers of all-cause mortality), thus influencing mortality. Method This is a cross-sectional analytical study in which data were collected from a regional cohort of 59 prevalent chronic hemodialysis patients using a national electronic database (eMED). Continuous data were analyzed using a regression model to assess for an association between HSD, IDWG% and UFR with albumin levels.ResultsFifty-six patients were included in the study. Multiple linear regression models demonstrated a cross-sectional association between longer HSD and higher serum albumin levels and a statistically significant positive correlation (r = 0.353; p < 0.05). No significant association of UFR (p = 0.169) and IDWG% (p = 0.549) with albumin was observed. Mean albumin was 38.07 ± 3.96 g/L in the HSD <240 min group compared to 40.50 ± 2.83g/L in the HSD ≥240 min group which was statistically significant (p < 0.05).ConclusionLonger HSD has a cross-sectional association with higher pre-dialysis serum albumin with patients having HSD ≥240 min demonstrating the highest levels of serum albumin. Our study suggests longer HSD may improve mortality in the dialysis population.

Highlights

  • Hemodialysis (HD) adequacy is primarily measured using small solute clearance based on the urea kinetic modelling (UKM) [1]

  • Mean albumin was 38.07 ± 3.96 g/L in the hemodialysis session duration (HSD)

  • Our study suggests longer HSD may improve mortality in the dialysis population

Read more

Summary

Introduction

Hemodialysis (HD) adequacy is primarily measured using small solute clearance based on the urea kinetic modelling (UKM) [1]. HD adequacy is a multifaceted process and UKM in isolation can be misleading when assessing HD patients. The landmark Hemodialysis Study (HEMO) did not demonstrate any significant difference in mortality or cardiac events between mean single pooled Kt/V (spKt/v) 1.3 (low dose) vs 1.7 (high dose) with a mean hemodialysis session duration (HSD) of 190 ± 23 vs 219 ± 23 min, respectively [2]. Large observational studies have identified short HSD, high ultrafiltration rates (UFR) and high intradialytic weight gain (IDWG) as important independent markers of mortality and adverse cardiovascular outcomes [4,5,6,7]. We hypothesize long HSD, slow UFR and lower IDWG% are associated with higher serum albumin levels, indicating better efficacy of dialysis and providing mortality benefits

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call